Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

CHERRY Aktie 112129002 / DE000A3CRRN9

12.08.2025 08:59:03

EQS-News: Cherry SE: CHERRY Digital Health Receives Provider Approval for TI Messenger

EQS-News: CHERRY SE / Key word(s): Regulatory Approval
Cherry SE: CHERRY Digital Health Receives Provider Approval for TI Messenger

12.08.2025 / 08:59 CET/CEST
The issuer is solely responsible for the content of this announcement.


 

  • The CHERRY TI Messenger offers a GDPR-compliant and gematik-approved solution for the healthcare sector.
  • The messenger enables communication among all healthcare stakeholders.
  • Planned expansions include video features, AI-powered automation, and communication for patients and health insurance providers.

 

Munich, 12 August 2025 – CHERRY Digital Health has reached another important milestone: The company has received official provider approval for the TI Messenger from gematik. This approval marks a decisive step in CHERRY’s efforts to offer innovative solutions for the digitalization of healthcare.

The CHERRY TI Messenger enables secure, GDPR-compliant, and cross-sector communication in the healthcare sector. Medical professionals can now communicate in real time, exchange findings and ask questions about medications — all via a single, user-friendly platform that can be used on both computers and smartphones. This allows flexible, device-independent use, significantly simplifying communication in healthcare.

Why is the TI Messenger needed? Currently, many healthcare providers still rely on fax, telephone, and analog communication channels. The TI Messenger offers a modern, digital alternative that meets the highest security standards and significantly increases communication efficiency. Unlike conventional messaging services like WhatsApp, the TI Messenger complies fully with GDPR requirements and is approved by gematik. This ensures the highest security standards for sensitive medical data and promotes collaboration across different healthcare sectors. Additionally, the TI Messenger is continuously being further developed. By the end of the third quarter, TI-M Pro will be available, enabling communication with patients and health insurance providers as well.

Dr. Philip Groth, Managing Director of CHERRY Digital Health, comments: " The provider approval by gematik confirms the quality and security of our TI Messenger solution. We are now ready to enter the market together with our partners and make a significant contribution to the digitalization of healthcare. Our goal is to make communication in the healthcare sector more efficient, secure, and user-friendly.

Key advantages of the CHERRY TI Messenger:

  1. Highest security standards through compliance with all gematik requirements and GDPR
  2. Seamless integration into existing workflows
  3. Flexible exchange of messages, images, and documents
  4. Cross-sector communication between all healthcare stakeholders
  5. Future-oriented solution with planned AI support for workflow automation

CHERRY TI Messenger is based on innovative technology from Awesome Technologies and was developed specifically for the needs of the German healthcare system. It complements the CHERRY Digital Health portfolio. 

With this provider approval, CHERRY Digital Health underlines its position as a leading provider of health technologies and a reliable partner for all stakeholders in healthcare.

For more information about the CHERRY TI Messenger, please click here.

 

About CHERRY Digital Health

CHERRY Digital Health is a leading provider of health technologies. With innovative products such as readers for health cards, hygiene keyboards and its own SaaS solution, the company sets new standards in the equipment of clinics, practices and pharmacies. Through close cooperation with hospitals, doctors' practices and medical professionals, CHERRY Digital Health ensures the highest standards and customer-oriented solutions. Certified quality and continuous development make CHERRY Digital Health a reliable partner for all players in the healthcare sector.

 

PRESS CONTACT

Lauren Sawyer

CHERRY Press Team

cherryuk@piabo.net

 

PRESSEKONTAKT

Claire Dove

CHERRY Presseteam

cherry@piabo.net



12.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cherry SE
Rosental 7, c/o Mindspace
80331 Munich
Germany
ISIN: DE000A3CRRN9
WKN: A3CRRN
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2182490

 
End of News EQS News Service

2182490  12.08.2025 CET/CEST

Analysen zu CHERRY

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

KI Aktien – Gewinner der Digitalisierung – Wall Street Live mit Tim Schäfer

In dieser Folge sprechen wir mit Tim Schäfer live aus New York über den aktuellen Stand der KI-Aktien. Sind die Kurse von Nvidia, Microsoft, Meta, Amazon, Alphabet und Apple noch gerechtfertigt – oder stehen wir kurz vor einer Spekulationsblase?

📈 Tim analysiert die Zahlen, Investitionen und Bewertungen der grossen Tech-Konzerne und zeigt, wie viel Kapital derzeit in KI-Infrastruktur fliesst. Zudem diskutieren wir, welche Randbereiche vom KI-Boom profitieren könnten – etwa Rechenzentren, Stromversorger oder Hardwarehersteller.

Themen im Video:
🔹Die „Magnificent 7“ im Check: Meta, Microsoft, Nvidia, Amazon, Alphabet, Apple
🔹Investitionen in KI: 71 Mrd. bei Meta, 120 Mrd. bei Microsoft
🔹Nvidia: Marktführer, aber extrem teuer
🔹Apple: Aufholjagd oder zu spät dran?
🔹Gefahr einer KI-Blase?
🔹Welche Alternativen bieten sich für Langfristinvestoren?
🔹Rechenzentren, Energieanbieter & Zulieferer im Fokus
🔹Wie Tim mit Rücksetzern und Seitwärtsphasen umgeht
🔹Erste Anzeichen für eine neue Superintelligenz?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

KI Aktien – Gewinner der Digitalisierung – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’873.95 19.48 BWDSCU
Short 13’148.15 13.59 B7ZS2U
Short 13’627.31 8.87 BTASKU
SMI-Kurs: 12’370.57 05.09.2025 17:30:18
Long 11’862.90 19.95 SZNBDU
Long 11’588.73 13.90 BH8SXU
Long 11’079.20 8.90 B38SLU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

CHERRY 0.71 -3.77% CHERRY

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}